{"id":382926,"date":"2022-11-29T12:30:00","date_gmt":"2022-11-29T12:30:00","guid":{"rendered":"https:\/\/omni48.com\/?p=382926"},"modified":"2022-11-29T13:03:00","modified_gmt":"2022-11-29T13:03:00","slug":"bristol-myers-squibb-share-price-growth-in-2022-best-for-a-decade-but-2023-could-better-it","status":"publish","type":"post","link":"https:\/\/omni48.com\/news\/bristol-myers-squibb-share-price-growth-in-2022-best-for-a-decade-but-2023-could-better-it","title":{"rendered":"Bristol Myers Squibb: Share Price Growth In 2022 Best For A Decade – But 2023 Could Better It"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Bristol Myers Squibb is a pharmaceutical powerhouse after its Celgene acquisition. The company’s revenues in 2022 will be down slightly year-on-year as Revlimid sales fall from…<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[36,1],"tags":[],"class_list":["post-382926","post","type-post","status-publish","format-standard","hentry","category-markets","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/382926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/comments?post=382926"}],"version-history":[{"count":0,"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/382926\/revisions"}],"wp:attachment":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/media?parent=382926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/categories?post=382926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/tags?post=382926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}